CuraGen Provides Update On Phase-II Cancer Trial
Published: 17-Jun-2009
CR011-vcMMAE is meant for the treatment of advanced breast cancer
CuraGen’s phase I/II trial, evaluating CR011-vcMMAE for the treatment of advanced breast cancer, has met the efficacy criteria for advancement to the second stage of enrollment.
CR011-vcMMAE is an antibody-drug conjugate (ADC) that consists of a fully-human monoclonal antibody, CR011, linked to a potent cell-killing drug, monomethyl-auristatin E (MMAE).
CR011-vcMMAE is currently in two phase-II trials assessing its safety and efficacy in the treatment of melanoma and metastatic breast cancer.
So far, 29 patients have been enrolled in the trial, including 15 in the phase-II portion. Two of the first four evaluable phase-II patients were progression-free at 12 weeks, therefore, as part of the Simon 2-Stage design, the phase-II trial will now advance to the second stage, said the company.
Delicious
Digg
Reddit
Stumble
Facebook
LinkedInNetwork Sites
Mail sent successfully
Suppliers To This Sector
Browse A-Z
Almac
Drug Development Solutions ...
STARLIMS
Benefits for Life Science Labs ...
Parenteral Drug Association (PDA)
Pharmaceutical Information and Education Services ...
Burkert Fluid Control Systems
Fluid and Gas Control Systems ...
IMCOR
LIMS and Laboratory Informatics Consultancy ...
Umicore Precious Metals Chemistry
Chemicals and Catalysts for Industrial Applications ...
White Papers
Browse A-Z
Water Treatment
From the control room to the downstream processing area and with an eye on utilities servi ...
A Vaccinne Bioassay Case Study – A Successful Strategic Outsourcing Model
Increasingly, pharma and biotech firms are searching for new drivers of revenue and profit ...
USB HotStart-IT for Real Time PCR
USB® Products from Affymetrix have a long-standing reputation in the life science marketpl ...
Enabling Drug Delivery Deal Making
Transdermal drug delivery: Time for a closer look. To find out more download this free whi ...
Automating Training Control Processes to Comply with FDA Requirements
Well-managed training programs minimize the risk of non-compliance and improve product qua ...
TNO Pharma Services: From Discovery to the Clinic
Our kinetics & metabolism experts can help you select and further develop your candidate d ...
